Aylward, Philip E.

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

Roe, M. T., Armstrong, P. W., Fox, K. A. A., White, H. D., Prabhakaran, D., Goodman, S. G., Cornel, J. H., Bhatt, D. L., Clemmensen, P., Martinez, F., et al. (2012) · New England Journal of Medicine

Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

Cited by 874

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

Bittner, V. A., Szarek, M., Aylward, P. E., Bhatt, D. L., Diaz, R., Edelberg, J. M., Fras, Z., Goodman, S. G., Halvorsen, S., Hanotin, C., et al. (2020) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 572

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., Budaj, A. J., Diaz, R., Goodman, S. G., Hanotin, C., et al. (2019) · The Lancet Diabetes & Endocrinology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 315

Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial

O’Donoghue, M. L., Glaser, R., Cavender, M. A., Aylward, P. E., Bonaca, M. P., Budaj, A., Davies, R. Y., Dellborg, M., Fox, K. A. A., Gutierrez, J. A. T., et al. (2016) · JAMA

Acute Myocardial Infarction ResearchCardiac Fibrosis and Remodeling

Cited by 249

Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction

Bohula, E. A., Bonaca, M. P., Braunwald, E., Aylward, P. E., Corbalan, R., De Ferrari, G. M., He, P., Lewis, B. S., Merlini, P. A., Murphy, S. A., et al. (2016) · Circulation

Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

Cited by 168

Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease – A STABILITY Substudy

Held, C., Hadziosmanovic, N., Aylward, P. E., Hagström, E., Hochman, J. S., Stewart, R. A. H., White, H. D., & Wallentin, L. (2022) · Journal of the American Heart Association

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Disease and Adiposity

Cited by 94

Impact of a regionalised clinical cardiac support network on mortality among rural patients with myocardial infarction

Tideman, P. A., Tirimacco, R., Senior, D. P., Setchell, J. J., Huynh, L. T., Tavella, R., Aylward, P. E. G., & Chew, D. P. B. (2014) · Medical Journal of Australia

Acute Myocardial Infarction ResearchCardiac Arrest and Resuscitation

Cited by 75

Sensitization of aortic and cardiac baroreceptors by arginine vasopressin in mammals.

Abboud, F. M., Aylward, P. E., Floras, J. S., & Gupta, B. N. (1986) · The Journal of Physiology

Heart Rate Variability and Autonomic ControlCardiovascular, Neuropeptides, and Oxidative Stress Research

Cited by 53

Effects of vasopressin on the circulation and its baroreflex control in healthy men.

Aylward, P. E., Floras, J. S., Leimbach, W. N., & Abboud, F. M. (1986) · Circulation

Heart Rate Variability and Autonomic ControlCardiovascular Syncope and Autonomic Disorders

Cited by 37

Inhibition of muscle sympathetic nerve activity in humans by arginine vasopressin

Floras, J. S., Aylward, P. E., Abboud, F. M., & Mark, A. L. (1987) · Hypertension

Heart Rate Variability and Autonomic ControlCardiovascular, Neuropeptides, and Oxidative Stress Research

Cited by 21